Cargando…
Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysis
BACKGROUND: The present study aims to better understand the efficacy and safety of mesenchymal stromal cells (MSCs) in treating severe/critical patients with COVID-19. METHODS: PubMed, the Cochrane Library, and the Chinese electronic database CNKI were searched from inception up to Dec 19, 2021. Ori...
Autores principales: | Yao, Weiqi, Dong, Haibo, Qi, Ji, Zhang, Yu, Shi, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270852/ https://www.ncbi.nlm.nih.gov/pubmed/35844767 http://dx.doi.org/10.1016/j.eclinm.2022.101545 |
Ejemplares similares
-
Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives
por: Yao, Weiqi, et al.
Publicado: (2022) -
Safety and efficacy of mesenchymal stem cells in COVID‐19 patients: A systematic review and meta‐analysis
por: Yan, Cai, et al.
Publicado: (2023) -
Systematic review with meta‐analysis: Safety and efficacy of local injections of mesenchymal stem cells in perianal fistulas
por: Ciccocioppo, Rachele, et al.
Publicado: (2019) -
Efficacy and safety of mesenchymal stem cells in the treatment of systemic sclerosis: a systematic review and meta-analysis
por: Cui, Jiehan, et al.
Publicado: (2022) -
Efficacy and safety of mesenchymal stem cell therapy in liver cirrhosis: a systematic review and meta-analysis
por: Lu, Wenming, et al.
Publicado: (2023)